736 related articles for article (PubMed ID: 29611079)
1. Waitlist Outcomes in Liver Transplant Candidates with High MELD and Severe Hepatic Encephalopathy.
Gadiparthi C; Cholankeril G; Yoo ER; Hu M; Wong RJ; Ahmed A
Dig Dis Sci; 2018 Jun; 63(6):1647-1653. PubMed ID: 29611079
[TBL] [Abstract][Full Text] [Related]
2. Hepatic encephalopathy is associated with significantly increased mortality among patients awaiting liver transplantation.
Wong RJ; Gish RG; Ahmed A
Liver Transpl; 2014 Dec; 20(12):1454-61. PubMed ID: 25155379
[TBL] [Abstract][Full Text] [Related]
3. Should All Status 1A Patients Be Prioritized Over High MELD Patients? Concept of Risk Stratification in Extremely Ill Liver Transplant Recipients.
Safwan M; Nwagu U; Collins K; Abouljoud M; Nagai S
Transplantation; 2019 Oct; 103(10):2121-2129. PubMed ID: 30747840
[TBL] [Abstract][Full Text] [Related]
4. End-stage liver disease patients with MELD >40 have higher waitlist mortality compared to Status 1A patients.
Ahn J; Bhuket T; Mosadeghi S; Frenette C; Liu B; Wong RJ
Hepatol Int; 2016 Sep; 10(5):838-46. PubMed ID: 27221700
[TBL] [Abstract][Full Text] [Related]
5. Predictors of Waitlist Mortality in Portopulmonary Hypertension.
DuBrock HM; Goldberg DS; Sussman NL; Bartolome SD; Kadry Z; Salgia RJ; Mulligan DC; Kremers WK; Kawut SM; Krowka MJ; Channick RN
Transplantation; 2017 Jul; 101(7):1609-1615. PubMed ID: 28207639
[TBL] [Abstract][Full Text] [Related]
6. Factors Associated with Survival of Patients With Severe Acute-On-Chronic Liver Failure Before and After Liver Transplantation.
Sundaram V; Jalan R; Wu T; Volk ML; Asrani SK; Klein AS; Wong RJ
Gastroenterology; 2019 Apr; 156(5):1381-1391.e3. PubMed ID: 30576643
[TBL] [Abstract][Full Text] [Related]
7. Inequity in organ allocation for patients awaiting liver transplantation: Rationale for uncapping the model for end-stage liver disease.
Nadim MK; DiNorcia J; Ji L; Groshen S; Levitsky J; Sung RS; Kim WR; Andreoni K; Mulligan D; Genyk YS
J Hepatol; 2017 Sep; 67(3):517-525. PubMed ID: 28483678
[TBL] [Abstract][Full Text] [Related]
8. Hepatic encephalopathy expands the predictivity of model for end-stage liver disease in liver transplant setting: Evidence by means of 2 independent cohorts.
Lucidi C; Ginanni Corradini S; Abraldes JG; Merli M; Tandon P; Ferri F; Parlati L; Lattanzi B; Poli E; Di Gregorio V; Farcomeni A; Riggio O
Liver Transpl; 2016 Oct; 22(10):1333-42. PubMed ID: 27434824
[TBL] [Abstract][Full Text] [Related]
9. More severe deficits in functional status associated with higher mortality among adults awaiting liver transplantation.
McCabe P; Wong RJ
Clin Transplant; 2018 Sep; 32(9):e13346. PubMed ID: 29979466
[TBL] [Abstract][Full Text] [Related]
10. Testing liver allocation in São Paulo, Brazil: the relationship of model for end-stage liver disease implementation with a reduction in waiting-list mortality.
Salvalaggio PR; Afonso RC; Pereira LA; Ferraz-Neto BH
Transplant Proc; 2012 Oct; 44(8):2283-5. PubMed ID: 23026574
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of liver transplantation for end-stage biliary disease: A comparative study with end-stage liver disease.
Lai YH; Duan WD; Yu Q; Ye S; Xiao NJ; Zhang DX; Huang ZQ; Yang ZY; Dong JH
World J Gastroenterol; 2015 May; 21(20):6296-303. PubMed ID: 26034365
[TBL] [Abstract][Full Text] [Related]
12. Effects of Allocating Livers for Transplantation Based on Model for End-Stage Liver Disease-Sodium Scores on Patient Outcomes.
Nagai S; Chau LC; Schilke RE; Safwan M; Rizzari M; Collins K; Yoshida A; Abouljoud MS; Moonka D
Gastroenterology; 2018 Nov; 155(5):1451-1462.e3. PubMed ID: 30056096
[TBL] [Abstract][Full Text] [Related]
13. Impact of MELD score implementation on liver allocation: experience at a Brazilian center.
da Silva Machado AG; de Medeiros Fleck A; Marroni C; Zanotelli ML; Cantisani G; de Mello Brandão AB
Ann Hepatol; 2013; 12(3):440-7. PubMed ID: 23619261
[TBL] [Abstract][Full Text] [Related]
14. Improved posttransplant mortality after share 35 for liver transplantation.
Kwong AJ; Goel A; Mannalithara A; Kim WR
Hepatology; 2018 Jan; 67(1):273-281. PubMed ID: 28586179
[TBL] [Abstract][Full Text] [Related]
15. Serum sodium and survival benefit of liver transplantation.
Sharma P; Schaubel DE; Goodrich NP; Merion RM
Liver Transpl; 2015 Mar; 21(3):308-13. PubMed ID: 25504743
[TBL] [Abstract][Full Text] [Related]
16. A revised model for end-stage liver disease optimizes prediction of mortality among patients awaiting liver transplantation.
Leise MD; Kim WR; Kremers WK; Larson JJ; Benson JT; Therneau TM
Gastroenterology; 2011 Jun; 140(7):1952-60. PubMed ID: 21334338
[TBL] [Abstract][Full Text] [Related]
17. Survival outcomes in liver transplant recipients with Model for End-stage Liver Disease scores of 40 or higher: a decade-long experience.
Panchal HJ; Durinka JB; Patterson J; Karipineni F; Ashburn S; Siskind E; Ortiz J
HPB (Oxford); 2015 Dec; 17(12):1074-84. PubMed ID: 26373873
[TBL] [Abstract][Full Text] [Related]
18. Improved retransplant outcomes: early evidence of the share35 impact.
Brooks JT; Koizumi N; Neglia E; Gdoura B; Wong TW; Kwon C; Smith TE; Ortiz J
HPB (Oxford); 2018 Jul; 20(7):649-657. PubMed ID: 29500002
[TBL] [Abstract][Full Text] [Related]
19. Impact of the hepatopulmonary syndrome MELD exception policy on outcomes of patients after liver transplantation: an analysis of the UNOS database.
Goldberg DS; Krok K; Batra S; Trotter JF; Kawut SM; Fallon MB
Gastroenterology; 2014 May; 146(5):1256-65.e1. PubMed ID: 24412528
[TBL] [Abstract][Full Text] [Related]
20. Moderate ascites identifies patients with low model for end-stage liver disease scores awaiting liver transplantation who have a high mortality risk.
Somsouk M; Kornfield R; Vittinghoff E; Inadomi JM; Biggins SW
Liver Transpl; 2011 Feb; 17(2):129-36. PubMed ID: 21280185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]